 Elaine Reno
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Travel | 3 | 2023 | 116 | 1.560 |
Why?
| | Altitude Sickness | 3 | 2019 | 163 | 1.300 |
Why?
| | Toxoplasmosis | 1 | 2023 | 31 | 0.940 |
Why?
| | Toxoplasma | 1 | 2023 | 34 | 0.940 |
Why?
| | Sunlight | 1 | 2022 | 60 | 0.850 |
Why?
| | Water Purification | 1 | 2022 | 131 | 0.770 |
Why?
| | Yellow Fever | 1 | 2020 | 7 | 0.750 |
Why?
| | Altitude | 3 | 2022 | 422 | 0.750 |
Why?
| | Massive Hepatic Necrosis | 1 | 2019 | 3 | 0.710 |
Why?
| | Hepatitis A | 1 | 2019 | 27 | 0.700 |
Why?
| | Social Media | 1 | 2021 | 133 | 0.680 |
Why?
| | Endometrial Neoplasms | 3 | 2009 | 144 | 0.660 |
Why?
| | Radiology | 1 | 2021 | 199 | 0.650 |
Why?
| | Students, Medical | 1 | 2021 | 311 | 0.590 |
Why?
| | Telemedicine | 2 | 2022 | 664 | 0.550 |
Why?
| | Mental Disorders | 1 | 2023 | 939 | 0.530 |
Why?
| | Hypoxia | 1 | 2019 | 963 | 0.440 |
Why?
| | Suicide | 1 | 2017 | 500 | 0.400 |
Why?
| | Protein Kinase C-delta | 2 | 2009 | 69 | 0.380 |
Why?
| | Depression | 1 | 2017 | 1132 | 0.350 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 155 | 0.340 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1794 | 0.310 |
Why?
| | Adenocarcinoma | 2 | 2009 | 812 | 0.250 |
Why?
| | Antibodies, Protozoan | 1 | 2023 | 28 | 0.240 |
Why?
| | Seroepidemiologic Studies | 1 | 2023 | 146 | 0.230 |
Why?
| | Travel-Related Illness | 1 | 2023 | 5 | 0.230 |
Why?
| | Apoptosis | 3 | 2009 | 2484 | 0.230 |
Why?
| | Plastics | 1 | 2022 | 35 | 0.220 |
Why?
| | Propensity Score | 1 | 2023 | 242 | 0.220 |
Why?
| | Immunoglobulin M | 1 | 2023 | 253 | 0.210 |
Why?
| | Water Microbiology | 1 | 2022 | 78 | 0.210 |
Why?
| | Disinfection | 1 | 2022 | 108 | 0.200 |
Why?
| | Yellow Fever Vaccine | 1 | 2020 | 6 | 0.190 |
Why?
| | Latin America | 1 | 2020 | 74 | 0.180 |
Why?
| | Africa | 1 | 2020 | 100 | 0.180 |
Why?
| | Immunization, Secondary | 1 | 2020 | 85 | 0.180 |
Why?
| | Humans | 14 | 2023 | 118972 | 0.180 |
Why?
| | Immunoglobulin G | 1 | 2023 | 788 | 0.180 |
Why?
| | Peru | 1 | 2019 | 59 | 0.170 |
Why?
| | Academic Medical Centers | 1 | 2022 | 422 | 0.170 |
Why?
| | Radiography | 1 | 2021 | 861 | 0.170 |
Why?
| | Escherichia coli | 1 | 2022 | 758 | 0.160 |
Why?
| | Fatal Outcome | 1 | 2019 | 287 | 0.160 |
Why?
| | Exercise Tolerance | 1 | 2019 | 233 | 0.150 |
Why?
| | Drug Utilization | 1 | 2018 | 169 | 0.150 |
Why?
| | Sinusitis | 1 | 2018 | 175 | 0.140 |
Why?
| | Headache | 1 | 2016 | 128 | 0.140 |
Why?
| | Migraine Disorders | 1 | 2016 | 79 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1384 | 0.130 |
Why?
| | Oxygen | 1 | 2019 | 854 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2018 | 482 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1355 | 0.120 |
Why?
| | Middle Aged | 4 | 2019 | 27617 | 0.110 |
Why?
| | Male | 5 | 2023 | 57801 | 0.110 |
Why?
| | Female | 9 | 2023 | 61564 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2674 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 1864 | 0.100 |
Why?
| | Protein Kinase C-alpha | 1 | 2009 | 43 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2436 | 0.090 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 139 | 0.090 |
Why?
| | Etoposide | 1 | 2009 | 149 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2009 | 100 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1510 | 0.080 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 160 | 0.080 |
Why?
| | Risk Factors | 2 | 2019 | 9000 | 0.080 |
Why?
| | Leiomyoma | 1 | 2008 | 45 | 0.080 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 311 | 0.080 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 285 | 0.080 |
Why?
| | Phosphorylation | 2 | 2009 | 1633 | 0.080 |
Why?
| | Uterine Neoplasms | 1 | 2008 | 76 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2022 | 12978 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 113 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2009 | 828 | 0.070 |
Why?
| | DNA Damage | 1 | 2009 | 357 | 0.070 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 381 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2007 | 874 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2007 | 580 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2009 | 2275 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 1 | 2009 | 811 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1691 | 0.060 |
Why?
| | Wilderness | 1 | 2023 | 17 | 0.060 |
Why?
| | Nausea | 1 | 2023 | 107 | 0.050 |
Why?
| | United States | 1 | 2019 | 12555 | 0.050 |
Why?
| | Vomiting | 1 | 2023 | 123 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 2851 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1597 | 0.050 |
Why?
| | Signal Transduction | 1 | 2009 | 4709 | 0.040 |
Why?
| | Mice | 2 | 2009 | 15520 | 0.030 |
Why?
| | Acute Disease | 1 | 2016 | 940 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1781 | 0.030 |
Why?
| | Logistic Models | 1 | 2016 | 1901 | 0.030 |
Why?
| | Age Factors | 1 | 2018 | 2995 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 5690 | 0.020 |
Why?
| | Animals | 2 | 2009 | 33381 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 93 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 65 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 69 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1200 | 0.020 |
Why?
| | Luciferases | 1 | 2009 | 143 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 83 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 195 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 109 | 0.020 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.020 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 143 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 77 | 0.020 |
Why?
| | Myometrium | 1 | 2008 | 35 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2008 | 268 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 154 | 0.020 |
Why?
| | Mice, Nude | 1 | 2009 | 663 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 420 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 533 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 550 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1194 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4196 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 4552 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 982 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 4708 | 0.020 |
Why?
| | Base Sequence | 1 | 2008 | 2159 | 0.020 |
Why?
| | Young Adult | 1 | 2016 | 10793 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 18480 | 0.010 |
Why?
| | Adult | 1 | 2016 | 31512 | 0.010 |
Why?
|
|
Reno's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|